0

CLINDESSE از شرکت PADAGIS US

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CLINDESSE از شرکت PADAGIS US

New Drug Application (NDA): 050793

Company: PADAGIS US

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CLINDESSE CLINDAMYCIN PHOSPHATE EQ 2% BASE CREAM;VAGINAL Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/30/2004 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/050793lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/050793ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/050793s000_ClinesseTOC.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/18/2017 SUPPL-22 Manufacturing (CMC)

Label is not available on this site.

03/01/2016 SUPPL-21 Manufacturing (CMC)

Label is not available on this site.

02/11/2016 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

09/22/2014 SUPPL-19 Manufacturing (CMC)

Label is not available on this site.

04/09/2013 SUPPL-18 Manufacturing (CMC)

Label is not available on this site.

01/16/2013 SUPPL-17 Manufacturing (CMC)

Label is not available on this site.

02/15/2012 SUPPL-15 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050793s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050793s015ltr.pdf

12/15/2010 SUPPL-14 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050793s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/050793s014ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/15/2012 SUPPL-15

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050793s015lbl.pdf
12/15/2010 SUPPL-14

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050793s014lbl.pdf
11/30/2004 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/050793lbl.pdf
بخوانید  CARBINOXAMINE MALEATE از شرکت MIKART
برچسب‌ها:

نظرات کاربران